[en] To assess the variation of thrombopoietin (TPO) responsiveness associated with megakaryocyte (MK) progenitor amplification, TPO dose-response curves were obtained for normal human, single-cell plated CD34(+)CD41(+) cells. The number of MKs per well was determined in situ and expressed as number of doublings (NbD). Dose-response curves of the mean frequency of clones of each size versus log TPO concentration showed highly significant differences in the TPO concentration needed for half-maximum generation of clones of different sizes (TPO50): 1.89 +/- 0.51 pg/mL for 1 MK clones; 7.75 +/- 0.81 pg/mL for 2 to 3 MK clones; 38.5 +/- 5.04 pg/mL for 4 to 7 MK clones, and 91.8 +/- 16.0 pg/mL for 8 to 15 MK clones. These results were consistent with a prediction of the generation-age model, because the number of previous doublings in vivo was inversely correlated with the number of residual doublings in vitro. TPO responsiveness decreased in vitro by a factor of 3.5 per doubling, reflecting the recruitment of progressively more ancestral progenitors. In support of this hypothesis, the more mature CD34(+)CD41(+)CD42(+) cell fraction had a lower TPO50 (P <.001), underwent fewer NbD (P <.001), and expressed a 2.8-fold greater median Mpl receptor density (P <.001) than the CD34(+)CD41(+)CD42(-) fraction. Progenitors that have completed their proliferative program have maximum factor responsiveness and are preferentially induced to terminal differentiation. (C) 2004 by The American Society of Hematology.
Disciplines :
Hematology
Author, co-author :
Paulus, Jean-Michel ; Université de Liège - ULiège -Belgium > Laboratory of Hematology, CHU du Sart Tilman, Liège
Debili, Najet; Institut National de la Santé et de la Recherche Médicale - (INSERM) U362 >
Larbret, Fréféric; Institut National de la Santé et de la Recherche Médicale - (INSERM) U362) > Institut Gustave Roussy, Villejuif, France
Levin, Jack; Univerity of California School of Medicine, San Francisco, USA > Department of Laboratory Medicine.
Vainchenker, William; Institut National de la Santé et de la Recherche Médicale - (INSERM) U362 > Institut Gustave Roussy, Villjuif, France
Language :
English
Title :
Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors
Publication date :
15 October 2004
Journal title :
Blood
ISSN :
0006-4971
eISSN :
1528-0020
Publisher :
American Society of Hematology, Washington, United States - District of Columbia
Volume :
104
Issue :
8
Pages :
2291-2298
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
Thrombocytopoiesis;
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique INSERM - Institut National de la Santé et de la Recherche Médicale
Commentary :
Progenitors that have completed their proliferative program have maximum factor responsiveness and are preferentially induced to terminal differentiation.
Paulus JM, Prenant M, Deschamps JF, Henry-Amar M. Polyploid megakaryocytes develop randomly from a multicompartmental system of committed progenitors. Proc Natl Acad Sci USA. 1982;79:4410-4414.
Paulus JM, Levin J, Debili N, Albert A, Vainchenker W. Genesis of clone size heterogeneity in megakaryocytic and other hemopoietic colonies. The stochastic model revisited. Exp Hematol. 2001:29:1256-1269.
Orkin SH. Transcription factors regulating early hematopoietic development and lineage commitment. In: Monroe JG, Rothenberg EV, eds. Molecular biology of B-cell and T-cell development. Totowa, NJ: Humana Press; 1999:41-54.
Matsumura I, Ishikawa J, Nakajima K, et al. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21WAF1/Cipl by STATS. Mol Cell Biol. 1997;17:2933-2943.
Nagata Y, Muro Y, Toobkoro K. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol. 1997:139:449-457.
Vitrat M, Cohen-Solal K, Pique C, et al. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood. 1998:91:3711-3723.
Huang C, Ferrell J Jr. Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA. 1996:93:10078-10083.
Ferrell JE, Machleder EM. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science. 1998;280:895-898.
Matsumura I, Nakajima K, Wakao H, et al. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol. 1998:18:4282-4290.
Rojnuckarin P, Drachmen JG, Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood. 1999;94:1273-1282.
Fichelson S, Freyssinier JM, Picard F, et al. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood. 1999;94:1601-1613.
Levin J, Levin FC, Penington DG, Metcalf D. Measurement of ploidy distribution in megakaryocyte colonies obtained from culture: with studies of the effects of thrombocytopenia. Blood. 1981;57:287-297.
Metcalf D. Clonal analysis of proliferation and differentiation of paired daughter cells: action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors. Proc Natl Acad Sci U S A. 1980:77:5327-5330.
Bruno E, Huffman R. Human megakaryocyte progenitor cells. Semin Hematol. 1998;35:183-191.
Francis GE, Berney JJ, Bodger MP, et al. Clone size potential and sensitivity to colony-stimulating activity: differentiation-linked properties of granulocyte-macrophage progenitor cells. Stem Cells. 1981:1:124-139.
Eaves CJ, Eaves AC. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood. 1978;52:1196-1210.
Long MW, Heffner CH, Gragowski LL. In vitro differences in responsiveness of early (BFU-Mk) and late (CFU-Mk) murine megakaryocyte progenitor cells. Prog Clin Biol Res. 1986;215:179-186.
Mintem J, Williams N, Jackson H. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness. Exp Hematol. 1997:25:1233-1239.
Leary AG, Strauss LC, Civin CI, Ogawa M. Disparate differentiation in hemopoietic colonies derived from human paired progenitors. Blood. 1985:66:327-332.
Huang S, Law P, Francis K, Palsson BO, Ho AD. Symmetry of initial cell divisions among primitive hematopoietic progenitor is independent of ontogenic age and regulatory molecules. Blood. 1999;94:2595-2604.
Punzel M, Liu D, Zhang T, et al. The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenvironment. Exp Hematol. 2003:31:339-347.
Takano H, Ema H, Sudo K, Nakauchi H. Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs. J Exp Med. 2004:199:295-302.
Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999;401:556-562.
Kondo M, Scherer DC, Miyamoto T, et al. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 2000:407:383-386.
Stellacci E, Testa U, Petrucci E, et al. Interferon regulatory factor-2 drives megakaryocytic differentiation. Biochem J. 2004:377:367-378.
Debili N, Coulombel L, Croisille L, et al. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood. 1996;88:1284-1296.
Debili N, Wendling F, Katz A, et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 1995;86:2516-2525.
Debili N, Robin C, Schiavon V, et al. Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates. Blood. 2001:97:2023-2030.
Kato T, Horie K, Hagiwara T, et al. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin. Exp Hematol. 1996;24:1209-1214.
Debili N, Wendling F, Cosman D, et al. The MpI receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood. 1995:85:391-401.
Debili N, Issaad C, Massé JM, et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood. 1992;80:3022-3035.
den Dekker E, van Abel M, van der Vuurst H, van Eys GJ, Akkerman JW, Heemskerk JW. Cell-to-cell variability in the differentiation program of human megakaryocytes. Biochim Biophys Acta. 2003:1643:85-94.
Deveaux S, Filipe A, Lemarchandel V, et al. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood. 1996:87:4678-4685.
Hashimoto Y, Ware J. Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. J Biol Chem. 1995:270:24532-24539.
Aitchison J, Brown J. The lognormal distribution with special reference to its use in economics. Cambridge, United Kingdom: Cambridge University Press: 1957.
Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995:80:179-185.
Dikic I, Schlessinger J, Lax I. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr Biol. 1994;4:702-708.
Gao FB, Apperly J, Raff M. Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev Biol. 1998:197:54-66.
Metcalf D, MacDonald HR. Heterogeneity of in vitro colony- and cluster-forming cells in the mouse marrow: segregation by velocity sedimentation. J Cell Physiol. 1975:85:643-654.
Labbaye C, Quarante MT, Pagliuca A, et al. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene. 2002:21:6669-6679.
Correa PN, Axelrad AA. Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulinlike growth factor 1. Blood. 1991:78:2823-2833.
Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol. 1992;20:391-394.
Kelley LL, Koury MJ, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood. 1993:82:2340-2352.
Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood. 2000;96:4142-4151.
Pestina TI, Cleveland JL, Yang CY, Zambetti GP, Jackson CW. MpI ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood. 2001;98:2084-2090.
Millot GA, Vainchenker W, Dumenil D, Svinarchuk F. Distinct effects of thrombopoietin depending on a threshold level of activated MpI in BaF-3 cells. J Cell Sci. 2002:115:2329-2337.
Kirito K, Watanabe T, Sawada K, et al. Thrombopoietin regulates Bcl-xL gene expression through Stats and phosphatidylinositol 3-kinase activation pathways. J Biol Chem. 2002;277:8329-8337.
Tanaka R, Katayama N, Ohishi K, et al. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood. 1995:86:73-79.
Muta K, Krantz SB, Bondurant MC, Dai CH. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood. 1995:86:572-580.
